Zusammenfassung der Ressource
Frage 1
Frage
Which of the following is NOT part of the Endogenous lipid metabolism pathway?
Antworten
-
IDL
-
VLDL
-
Liver
-
Chylomicrons
Frage 2
Frage
At what age should LOW risk males and females begin screening for CHD, respectively?
Antworten
-
35, 45
-
45, 35
-
25, 35
-
35, 25
Frage 3
Frage
Which of the following is a modifiable risk factor for CHD?
Frage 4
Frage
Which Rx can contribute to Hypertriglyceridemia?
Antworten
-
Estrogen
-
Beta Blockers
-
HCTZ
-
All of these
Frage 5
Frage
A patient has a lipid profile as follows:
Cholesterol 187
Triglycerides 197
HDL 50mg/dl
LDL 139
What can be concluded about this patient?
Frage 6
Frage
A patient has a lipid profile completed and you notice that his TG value is 1892 mg/dL. Classically, you might expect what findings upon physical examination?
Frage 7
Frage
Which of the following is true regarding Hyperlipidemia Rx?
Antworten
-
Fibric acids are most useful for lowering triglycerides
-
Resins are absolutely contraindicated in patients with TGs > 200 mg/dL
-
Nicotinic Acid, not Fibric Acid, is effective at raising HDL
-
Ezetimibe should never be combined with statins
Frage 8
Frage
Your patient has been taking statins and bile acid sequestrants for 6 months to lower his cholesterol. He comes back to your office and reports muscle pain all over his body and tells you his urine has a dark color. What is your next step?
Antworten
-
Lower the statins, check his CK
-
Stop the statins and check his CK
-
Stop both Rx, check the CK
-
Add NSAIDS to regimen, check CK
Frage 9
Frage
Who would not stand to benefit from statins?
Antworten
-
A 76yo diabetic with LDL 69mg/dL, no clinical ascvd.
-
Nondiabetic, no ASCVD with LDL 190mg/dL
-
A pt with stable angina
-
A nondiabetic without ASCVD with a 10-year ASCVD risk of 7.5%
Frage 10
Frage
You conclude a patient would benefit from Rx to control her lipid profile. Her hyperglycemia is a relative contraindication to what LDL-lowering medication?
Antworten
-
Fibric Acid
-
Statins
-
Resins
-
Nicotinic acid